← Leaderboards
Yuji Ikeno
Mayo Clinic Rochester
$7,893,155
Attributed
$7,893,155
Total exposure
12
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $914.7K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,893,155 · 11
VA$0 · 1
By mechanism
P30$3,152,187 · 7
P01$2,273,392 · 2
R01$2,008,068 · 1
R56$459,508 · 1
I01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Darren Baker$10,907,779
- Paul D. Robbins$18,718,334
- Jan M. Van Deursen$15,959,798
- Gary L Keeney$874,350
- Joao Passos$7,873,363
Others in their field
Top investigators on “Tissues”
- David Heimbrook · Leidos Biomedical Research, Inc.$346,311,904
- Lawrence Corey · Fred Hutchinson Cancer Center$230,011,824
- Larry Arthur$159,140,370
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Judith S. Currier · University Of California Los Angeles$138,805,403
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$138,805,403
Research focus
TissuesAge RelatedAgingAnimalsPathologyMolecularResearch PersonnelElderlyBiologicalLesionInsightSeveritiesCellsBiochemicalResourcesDatabasesMorbidity - Disease RateEnd Of LifePhysiologicalLongevityPlayAdipose TissueNeoplasticArchives
Grant awards (41)
Reduced thioredoxin in both the cytosol and mitochondria: a key modulator of age-related cancer development in Trx1KO x Trx2KO mice?$358,848
R01 · FY2025 · AG · contact PI
Pathology Core$216,562
P30 · FY2025 · AG · contact PI
Reduced thioredoxin in both the cytosol and mitochondria: a key modulator of age-related cancer development in Trx1KO x Trx2KO mice?$422,096
R01 · FY2024 · AG · contact PI
Pathology Core$290,686
P30 · FY2024 · AG · contact PI
Reduced thioredoxin in both the cytosol and mitochondria: a key modulator of age-related cancer development in Trx1KO x Trx2KO mice?$425,909
R01 · FY2023 · AG · contact PI
Geroscience Pathology and Cellular Histology$242,457
P01 · FY2023 · AG · contact PI
Pathology Core$180,127
P30 · FY2023 · AG · contact PI
Reduced thioredoxin in both the cytosol and mitochondria: a key modulator of age-related cancer development in Trx1KO x Trx2KO mice?$413,580
R01 · FY2022 · AG · contact PI
Geroscience Pathology and Cellular Histology$261,961
P01 · FY2022 · AG · contact PI
Pathology Core$180,611
P30 · FY2022 · AG · contact PI
Reduced thioredoxin in both the cytosol and mitochondria: a key modulator of age-related cancer development in Trx1KO x Trx2KO mice?$387,635
R01 · FY2021 · AG · contact PI
Geroscience Pathology and Cellular Histology$365,097
P01 · FY2021 · AG · contact PI
Pathology Core$161,946
P30 · FY2021 · AG · contact PI
Geroscience Pathology and Cellular Histology$210,262
P01 · FY2020 · AG · contact PI
Pathology Core$162,673
P30 · FY2020 · AG · contact PI
Geroscience Pathology and Cellular Histology$267,525
P01 · FY2019 · AG · contact PI
Pathology Core$114,603
P30 · FY2019 · AG · contact PI
Mechanisms by which Cu/ZnSOD overexpression improves metabolic health in rats$459,508
R56 · FY2018 · AG · contact PI
Pathology Core$114,602
P30 · FY2018 · AG · contact PI
Pathology Core$114,602
P30 · FY2017 · AG · contact PI
Pathology Core$114,602
P30 · FY2016 · AG · contact PI
Pathology Core$114,227
P30 · FY2015 · AG · contact PI
Anti-aging and anti-cancer effects of thioredoxins$0
I01 · FY2015 · VA · contact PI
Pathology Core$127,193
P30 · FY2014 · AG · contact PI
Anti-aging and anti-cancer effects of thioredoxins$0
I01 · FY2014 · VA · contact PI
PATHOLOGY$194,429
P01 · FY2013 · AG · contact PI
Pathology Core$122,571
P30 · FY2013 · AG · contact PI
Anti-aging and anti-cancer effects of thioredoxins$0
I01 · FY2013 · VA · contact PI
PATHOLOGY$213,020
P01 · FY2012 · AG · contact PI
Pathology Core$129,856
P30 · FY2012 · AG · contact PI
Anti-aging and anti-cancer effects of thioredoxins$0
I01 · FY2012 · VA · contact PI
PATHOLOGY$194,031
P01 · FY2011 · AG · contact PI
Pathology Core$138,465
P30 · FY2011 · AG · contact PI
PATHOLOGY$157,923
P01 · FY2010 · AG · contact PI
Pathology Core$131,647
P30 · FY2010 · AG · contact PI
PATHOLOGY CORE$190,039
P30 · FY2009 · AG · contact PI
PATHOLOGY$166,687
P01 · FY2009 · AG · contact PI
PATHOLOGY CORE$184,685
P30 · FY2008 · AG · contact PI
PATHOLOGY CORE$159,492
P30 · FY2007 · AG · contact PI
PATHOLOGY CORE$102,998
P30 · FY2006 · AG · contact PI
PATHOLOGY CORE$100,000
P30 · FY2005 · AG